J. Goldman & Co’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-5,363
| Closed | -$8.55M | – | 293 |
|
|
2018
Q1 | $8.55M | Buy |
5,363
+692
| +15% | +$1.1M | 0.36% | 40 |
|
|
2017
Q4 | $4.18M | Sell |
4,671
-11,536
| -71% | -$10.3M | 0.22% | 70 |
|
|
2017
Q3 | $5.83M | Sell |
16,207
-11,446
| -41% | -$4.12M | 0.29% | 52 |
|
|
2017
Q2 | $8.11M | Buy |
27,653
+19,976
| +260% | +$5.86M | 0.44% | 36 |
|
|
2017
Q1 | $2.7M | Sell |
7,677
-6,096
| -44% | -$2.15M | 0.13% | 106 |
|
|
2016
Q4 | $2.54M | Buy |
+13,773
| New | +$2.54M | 0.17% | 89 |
|
|
2015
Q4 | – | Sell |
-12,048
| Closed | -$1.98M | – | 207 |
|
|
2015
Q3 | $1.98M | Buy |
+12,048
| New | +$1.98M | 0.17% | 99 |
|
|
2013
Q3 | – | Sell |
-9,667
| Closed | -$1.68M | – | 205 |
|
|
2013
Q2 | $1.68M | Buy |
+9,667
| New | +$1.68M | 0.17% | 99 |
|